CureVac N.V. (5CV.F)

EUR 2.72

(-2.01%)

Operating Expenses Summary of CureVac N.V.

  • CureVac N.V.'s latest annual operating expenses in 2023 was 211.75 Million EUR , up 37.88% from previous year.
  • CureVac N.V.'s latest quarterly operating expenses in 2024 Q2 was 43.46 Million EUR , up 5.36% from previous quarter.
  • CureVac N.V. reported a annual operating expenses of 134.27 Million EUR in annual operating expenses 2022, down -51.53% from previous year.
  • CureVac N.V. reported a annual operating expenses of 277.05 Million EUR in annual operating expenses 2021, up 74.58% from previous year.
  • CureVac N.V. reported a quarterly operating expenses of 44.92 Million EUR for 2024 Q1, down -14.64% from previous quarter.
  • CureVac N.V. reported a quarterly operating expenses of 53.7 Million EUR for 2023 Q2, up 13.87% from previous quarter.

Annual Operating Expenses Chart of CureVac N.V. (2023 - 2018)

Historical Annual Operating Expenses of CureVac N.V. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 211.75 Million EUR 37.88%
2022 134.27 Million EUR -51.53%
2021 277.05 Million EUR 74.58%
2020 158.7 Million EUR 78.45%
2019 88.93 Million EUR 30.87%
2018 67.95 Million EUR 0.0%

Peer Operating Expenses Comparison of CureVac N.V.

Name Operating Expenses Operating Expenses Difference
BioNTech SE 2.52 Billion EUR 91.626%
Biotest Aktiengesellschaft 136.8 Million EUR -54.791%
Biotest Aktiengesellschaft 136.8 Million EUR -54.791%
BRAIN Biotech AG 24.94 Million EUR -749.02%
Formycon AG 23.73 Million EUR -792.234%
Heidelberg Pharma AG 27.81 Million EUR -661.27%
Medigene AG 20.54 Million EUR -930.935%